Risk Factors and Molecular Epidemiology of Community-Onset Extended-Spectrum β-Lactamase-Producing Escherichia coli Bacteremia

논문상세정보
' Risk Factors and Molecular Epidemiology of Community-Onset Extended-Spectrum β-Lactamase-Producing Escherichia coli Bacteremia' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • beta-lactamase
  • ctx-m
  • escherichia coli
  • risk factors
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
8,244 0

0.0%

' Risk Factors and Molecular Epidemiology of Community-Onset Extended-Spectrum β-Lactamase-Producing Escherichia coli Bacteremia' 의 참고문헌

  • Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extended-spectrum beta-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis
    Song W DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE 57 : 315 ~ 318 [2007]
  • Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extended-spectrum beta-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis
    Song W DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE 57 315-318 [2007]
  • Tuberculosis transmission in nontraditional settings: a decision-tree approach
    Kammerer JS Am J Prev Med 28 : 201 ~ 207 [2005]
  • Tuberculosis transmission in nontraditional settings: a decision-tree approach
    Kammerer JS Am J Prev Med 28 201-207 [2005]
  • The spread of CTX-M-type extended-spectrum beta-lactamases
    Rossolini GM Clin Microbiol Infect 14 (Suppl 1) : 33 ~ 41 [2008]
  • The spread of CTX-M-type extended-spectrum beta-lactamases
    Rossolini GM Clin Microbiol Infect 14 Suppl 1 33-41 [2008]
  • The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistance
    Kaye KS Infect Control Hosp Epidemiol 26 : 346 ~ 351 [2005]
  • The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistance
    Kaye KS Infect Control Hosp Epidemiol 26 346-351 [2005]
  • Risk-factors for emerging bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli
    Rodríguez-Baño J Clin Microbiol Infect 14 : 180 ~ 183 [2008]
  • Risk-factors for emerging bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli
    Rodríguez-Baño J Clin Microbiol Infect 14 180-183 [2008]
  • Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis
    Fonarow GC JAMA 293 : 572 ~ 580 [2005]
  • Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis
    Fonarow GC JAMA 293 572-580 [2005]
  • Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli
    Kang CI INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 36 (3) : 284 ~ 287 [2010]
  • Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli
    Kang CI INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 36 3 284-287 [2010]
  • Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment
    Tumbarello M Antimicrob Agents Chemother 51 : 1987 ~ 1994 [2007]
  • Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment
    Tumbarello M Antimicrob Agents Chemother 51 1987-1994 [2007]
  • Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae
    Anderson DJ Antimicrob Agents Chemother 50 : 1715 ~ 1720 [2006]
  • Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae
    Anderson DJ Antimicrob Agents Chemother 50 1715-1720 [2006]
  • Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement
    Cockerill FR CLSI [2010]
  • Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement
    Cockerill FR - [2010]
  • Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15
    Park SH BMC Infect Dis 12 : 149 ~ [2012]
  • Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15
    Park SH BMC Infect Dis 12 149- [2012]
  • Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4
    Peirano G Int J Antimicrob Agents 35 : 316 ~ 321 [2010]
  • Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4
    Peirano G Int J Antimicrob Agents 35 316-321 [2010]
  • Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review
    Harris AD Clin Infect Dis 32 : 1055 ~ 1061 [2001]
  • Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review
    Harris AD Clin Infect Dis 32 1055-1061 [2001]
  • International prospective study of Klebsiella pneumoniae bacteremia:implications of extended-spectrum beta-lactamase production in nosocomial Infections
    Paterson DL Ann Intern Med 140 26-32 [2004]
  • International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections
    Paterson DL Ann Intern Med 140 : 26 ~ 32 [2004]
  • Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15
    Nicolas-Chanoine MH J Antimicrob Chemother 61 : 273 ~ 281 [2008]
  • Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15
    Nicolas-Chanoine MH J Antimicrob Chemother 61 273-281 [2008]
  • Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock
    Kumar A Chest 136 : 1237 ~ 1248 [2009]
  • Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock
    Kumar A Chest 136 1237-1248 [2009]
  • Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality
    Peña C J Hosp Infect 68 : 115 ~ 122 [2008]
  • Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality
    Peña C J Hosp Infect 68 115-122 [2008]
  • Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis
    Harbarth S Am J Med 115 : 529 ~ 535 [2003]
  • Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis
    Harbarth S Am J Med 115 529-535 [2003]
  • Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection
    Hyle EP Arch Intern Med 165 : 1375 ~ 1380 [2005]
  • Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection
    Hyle EP Arch Intern Med 165 1375-1380 [2005]
  • Health care: associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections
    Friedman ND Ann Intern Med 137 791-797 [2002]
  • Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections
    Friedman ND Ann Intern Med 137 : 791 ~ 797 [2002]
  • Extended-spectrum betalactamase-producing Enterobacteriaceae: an emerging public-health concern
    Pitout JD Lancet Infect Dis 8 159-166 [2008]
  • Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes
    Lautenbach E Clin Infect Dis 32 1162-1171 [2001]
  • Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern
    Pitout JD Lancet Infect Dis 8 : 159 ~ 166 [2008]
  • Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae: Risk factors for infection and impact of resistance on outcomes
    Lautenbach E Clin Infect Dis 32 : 1162 ~ 1171 [2001]
  • Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States
    Johnson JR Clin Infect Dis 51 : 286 ~ 294 [2010]
  • Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States
    Johnson JR Clin Infect Dis 51 286-294 [2010]
  • Epidemiology and risk factors of community onset infections caused by extended-spectrum β-lactamase-producing Escherichia coli strains
    Kang CI J Clin Microbiol 50 : 312 ~ 317 [2012]
  • Epidemiology and risk factors of community onset infections caused by extended-spectrum β-lactamase-producing Escherichia coli strains
    Kang CI J Clin Microbiol 50 312-317 [2012]
  • Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community
    Pitout JD J Antimicrob Chemother 56 : 52 ~ 59 [2005]
  • Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community
    Pitout JD J Antimicrob Chemother 56 52-59 [2005]
  • Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15
    Coque TM Emerg Infect Dis 14 : 195 ~ 200 [2008]
  • Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15
    Coque TM Emerg Infect Dis 14 195-200 [2008]
  • Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea
    Ryoo NH JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 56 : 698 ~ 702 [2005]
  • Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea
    Ryoo NH JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 56 698-702 [2005]
  • Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli
    Jacoby GA J Clin Microbiol 34 : 908 ~ 911 [1996]
  • Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli
    Jacoby GA J Clin Microbiol 34 908-911 [1996]
  • Current Epidemiology and Growing Resistance of Gram- Negative Pathogens
    David M. Livermore The Korean Journal of Internal Medicine 27 (2) : 128 ~ 142 [2012]
  • Current Epidemiology and Growing Resistance of Gram- Negative Pathogens
    David M. Livermore The Korean Journal of Internal Medicine 27 2 128-142 [2012]
  • Control group selection is an important but neglected issue in studies of antibiotic resistance
    Harris AD Ann Intern Med 133 : 159 ~ [2000]
  • Control group selection is an important but neglected issue in studies of antibiotic resistance
    Harris AD Ann Intern Med 133 159- [2000]
  • Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis
    Rodríguez-Baño J Clin Infect Dis 50 : 40 ~ 48 [2010]
  • Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis
    Rodríguez-Baño J Clin Infect Dis 50 40-48 [2010]
  • Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli
    Rodríguez-Baño J Arch Intern Med 168 : 1897 ~ 1902 [2008]
  • Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli
    Rodríguez-Baño J Arch Intern Med 168 1897-1902 [2008]
  • Classification and regression trees (CART) for prediction of function at 1 year following head trauma
    Temkin NR J Neurosurg 82 : 764 ~ 771 [1995]
  • Classification and regression trees (CART) for prediction of function at 1 year following head trauma
    Temkin NR J Neurosurg 82 764-771 [1995]
  • Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea
    Kim SY Diagn Microbiol Infect Dis 76 : 486 ~ 490 [2013]
  • Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea
    Kim SY Diagn Microbiol Infect Dis 76 486-490 [2013]
  • CTX-M-14 and CTX-M-15 enzymes are the dominant type of extended-spectrum beta-lactamase in clinical isolates of Escherichia coli from Korea
    Song W JOURNAL OF MEDICAL MICROBIOLOGY 58 : 261 ~ 266 [2009]
  • CTX-M-14 and CTX-M-15 enzymes are the dominant type of extended-spectrum beta-lactamase in clinical isolates of Escherichia coli from Korea
    Song W JOURNAL OF MEDICAL MICROBIOLOGY 58 261-266 [2009]
  • Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph(1+) chronic myelogenous leukemia: a multicenter trial
    Kvasnicka HM J Clin Oncol 19 : 2994 ~ 3009 [2001]
  • Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph(1+) chronic myelogenous leukemia: a multicenter trial
    Kvasnicka HM J Clin Oncol 19 2994-3009 [2001]
  • Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: Risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome
    Kang CI Antimicrobial Agents and Chemotherapy 49 (2) : 760 ~ 766 [2005]
  • Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: Risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome
    Kang CI Antimicrobial Agents and Chemotherapy 49 2 760-766 [2005]
  • Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge
    Rodríguez-Baño J Clin Infect Dis 43 : 1407 ~ 1414 [2006]
  • Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge
    Rodríguez-Baño J Clin Infect Dis 43 1407-1414 [2006]
  • Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase: a case-control study of risk factors and outcomes
    Ho PL Scand J Infect Dis 34 : 567 ~ 573 [2002]
  • Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase: a case-control study of risk factors and outcomes
    Ho PL Scand J Infect Dis 34 567-573 [2002]
  • Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome
    Gudiol C J Antimicrob Chemother 65 : 333 ~ 341 [2010]
  • Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome
    Gudiol C J Antimicrob Chemother 65 333-341 [2010]
  • A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
    Charlson ME J Chronic Dis 40 : 373 ~ 383 [1987]
  • A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
    Charlson ME J Chronic Dis 40 373-383 [1987]
  • A decision tree for tuberculosis contact investigation
    Gerald LB Am J Respir Crit Care Med 166 : 1122 ~ 1127 [2002]
  • A decision tree for tuberculosis contact investigation
    Gerald LB Am J Respir Crit Care Med 166 1122-1127 [2002]